ARTICLE
|
doi:10.20944/preprints202309.1417.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
R-RAS2; RAS; GTPases; chronic lymphocytic leukemia; B-CLL; mouse model; ibrutinib; venetoclax; new therapies; cancer treatment
Online: 21 September 2023 (12:04:56 CEST)